Inovio Pharmaceuticals Inc (NASDAQ: INO) on Monday, soared 9.94% from the previous trading day, before settling in for the closing price of $1.61. Within the past 52 weeks, INO’s price has moved between $1.42 and $13.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 63.34%. The company achieved an average annual earnings per share of 40.80%. With a float of $36.42 million, this company’s outstanding shares have now reached $36.67 million.
Let’s determine the extent of company efficiency that accounts for 134 employees. In terms of profitability, gross margin is -629.42%, operating margin of -51616.91%, and the pretax margin is -11594429.84%.
Inovio Pharmaceuticals Inc (INO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Inovio Pharmaceuticals Inc is 0.69%, while institutional ownership is 36.49%.
Inovio Pharmaceuticals Inc (INO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.68 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.58% during the next five years compared to 22.92% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
Inovio Pharmaceuticals Inc (INO) is currently performing well based on its current performance indicators. A quick ratio of 2.77 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 295.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.98, a number that is poised to hit -0.69 in the next quarter and is forecasted to reach -1.99 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Looking closely at Inovio Pharmaceuticals Inc (NASDAQ: INO), its last 5-days average volume was 0.73 million, which is a drop from its year-to-date volume of 0.85 million. As of the previous 9 days, the stock’s Stochastic %D was 76.74%. Additionally, its Average True Range was 0.14.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 10.97%, which indicates a significant decrease from 82.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 92.38% in the past 14 days, which was lower than the 105.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9008, while its 200-day Moving Average is $4.8163. However, in the short run, Inovio Pharmaceuticals Inc’s stock first resistance to watch stands at $1.8150. Second resistance stands at $1.8600. The third major resistance level sits at $1.9500. If the price goes on to break the first support level at $1.6800, it is likely to go to the next support level at $1.5900. Now, if the price goes above the second support level, the third support stands at $1.5450.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
Market capitalization of the company is 64.91 million based on 36,667K outstanding shares. Right now, sales total 220 K and income totals -107,250 K. The company made 120 K in profit during its latest quarter, and -19,380 K in sales during its previous quarter.
